Inactive

MARKET SURVEY REQUEST: THIS IS A REQUEST FOR INFORMATION ONLY for market research and planning purposes only, as defined in FAR 15.201(e). This is not a solicitation or request for competitive proposa... MARKET SURVEY REQUEST: THIS IS A REQUEST FOR INFORMATION ONLY for market research and planning purposes only, as defined in FAR 15.201(e). This is not a solicitation or request for competitive proposals. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited. No solicitation document exists or is guaranteed to be issued as a result of this Notice. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted, and the Government will not reimburse respondents for preparation of the response. Response to this Notice is strictly voluntary and will not affect future ability to submit an offer if a solicitation is released. There is no bid package or solicitation document associated with this announcement. BACKGROUND: The Armed Forces Medical Examiner Systems (AFMES) provides the DoD and other Federal Agencies comprehensive Forensic Investigative Services, to include Forensic Pathology, DNA Forensics, Forensic Toxicology, and Medical Mortality Surveillance. AFMES is not only the single worldwide Medical Examiner System, but it also supports the entire U.S. Federal Government. REQUIREMENT: AFMES has a Requirement for a Contractor to provide standard products as well as customized orders upon request for newly identified emerging drugs. Ampules containing neat solutions or dried materials are used in the preparation of calibrators, standards and/or control materials. These materials are used to quantitate many of the frequently analyzed synthetic cannabinoids and also the non-frequently analyzed drugs reported by the AFMES. The list of Chemicals, includes (but is not limited to), the Following: 1 - AM2201 N-(4-hydroxypentyl) 1 mg 2 - AM2201-d5 1 mg 3 - Mephedrone (HCl), 5mg 4 - JWH 250 N-pentanoic acid 1 mg 5 - JWH 210 N-pentanoic acid 1 mg 6 - 3-methoxy PCP (hydrochloride) 5 mg 7 - DOET 5 mg 8 - DOM 5 mg 9 - 6-APDB (hydrochloride) 1 mg 10 - D2PM (hydrochloride) 5 mg 11 - Ketazolam, 1mg 12 - AM2201 N-(4-hydroxypentyl) 100 ?g 13 - DiPT 5 mg 14 - 5-methoxy AMT 5 mg 15 - Telmisartan, 50mg 16 - MAM2201-d5 1 mg 17 - JWH 018 N-pentanoic acid 1 mg 18 - UR144 N-pentanoic acid 1 mg 19 - UR144 N-(5-hydroxypentyl) 1 mg 20 - MAM2201 N-pentanoic acid 1 mg 21 - 25I-NBMD (hydrochloride) 1 mg 22 - Irbesartan, 10mg 23 - Xylazine, 1 g 24 - MBDB (hydrochloride) 5 mg 25 - ADB-FUBINACA 1 mg 26 - PB-22-d9 1 mg 27 - JWH 081 N-(5-hydroxypentyl) 100 ?g 28 - MAM2201 N-pentanoic acid metabolite-d5 100 ?g 29 - UR-144 N-pentanoic acid 1 mg 30 - BB-22 3-carboxyindole 1 mg 31 - 5-fluoro PB22 3-carboxyindole 1 mg 32 - PB-22 3-carboxyindole 1 mg 33 - RH-34, 1 mg SUBMITTALS: Summaries of the services as listed above shall be no more than Ten (10) pages in length (1 side of 1 sheet of paper counts as a “Page”), and shall describe their capability to fulfill this requirement. Interested Parties shall provide their business size status based upon NAICS code 325199, All Other Basic Organic Chemical Manufacturing, with a Small Business Size Standard of 1,250 Employees, and their CAGE code as registered at beta.sam.gov. Interested Parties may include item brochure information with the summary package by the Government's requested date of submittal of 13 July 2022. Interested parties shall submit information in response to this RFI to: jennifer.s.bassett.civ@mail.mil. Responses shall be submitted and received via Email no later than Two O’clock Post Meridian Eastern Standard Time (2:00PM EST) Thursday, 13 July 2022. Documents shall be electronic in Microsoft Word, Excel, Power Point, and/or Adobe Portable Document Format (PDF) and provided as attachments to the Email. No telephonic responses to this RFI will be considered. Questions concerning this Request For Information (RFI) may be addressed by contacting: jennifer.s.bassett.civ@mail.mil. All information received in response to this RFI that is marked proprietary will be handled accordingly. Responses to this RFI are not offers for a contract and will not be used by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. Vendors having the services that they believe would be suitable for operations as described herein shall submit all supporting documentation requested by this RFI to the Point of Contact (POC) noted above. Please provide information on your organization in the following areas: Company Name, Address and Single Point of Contact with Name, Title, Telephone Number and E-mail Address. DUNS Number and Cage Code Confirmation of Current Active Registration in System for Award Management (SAM) Primary NAICS Code(s) and Business Size (i.e., small/large) GSA Schedule, If Available Commercial Price List, if GSA schedule is Not Available Product Specific Brochures Literature PROVISIONS AND CLAUSES: 52.215-3 Request for Information or Solicitation for Planning Purposes. Request for Information or Solicitation for Planning Purposes (Oct 1997) (a) The Government does not intend to award a contract on the basis of this solicitation or to otherwise pay for the information solicited except as an allowable cost under other contracts as provided in subsection 31.205-18, Bid and proposal costs, of the Federal Acquisition Regulation. (b) Although "Proposal" and "Offeror" are used in this Request for Information, your response will be treated as information only. It shall not be used as a proposal. (c) This solicitation is issued for the purpose of: SYNTHETIC CANNABINOIDS. (End of Provision)